WuXi Biologics WKN: A2QJCN ISIN: KYG970081173 Forum: Aktien User: Summer.76

Ja stimmt, ich bin aber voll investiert,,😉😉

Was ein klasse Unternehmen. Irgendwie traurig, dass es in Deutschland bzw. Europa so unbekannt ist 🤷‍♂️

WuXi Biologics (2269 HK) rose 6%, survey minutes revealed that this year's revenue and net profit growth rate is around 50% https://m.jrj.com.cn/madapter/hk/2021/05/25140632816219.shtml WuXi Biologics (2269 HK), which was selected as one of the top ten core potential assets of Gelonghui in 2021 "Betting on China", was significantly stronger today. It rose 6.01% to 116.4 Hong Kong dollars during the day, and its market value Approaching 490 billion Hong Kong dollars. A summary of WuXi Biologics’ research and exchanges revealed: “The company’s revenue contribution from CMO projects and the number of projects will increase significantly this year. It is conservatively estimated that there will be 6 CMO projects this year, excluding other orders that may be obtained from outside. The company’s feedback to the market is that this year’s revenue and net profit have increased by about 50% year-on-year."

The HSI opens 0.14% lower https://www.hstong.com/news/detail/21052409250171076 According to news on May 24, US stocks closed mixed on Friday. The decline in Bitcoin dragged down technology stocks and the Nasdaq. The S&P index recorded a second consecutive week of decline. At today's opening, the Hang Seng Index opened lower by 0.14% to 28417.99 points; the State-owned Enterprise Index fell 0.5%, the red chip index fell 0.09%, and the Hang Seng Technology fell 0.8%.

Healthcare Gains Drive Chinese Stocks Even Higher https://www.etftrends.com/china-insights-channel/healthcare-gains-drive-chinese-stocks-higher/amp/

Bearish block trade of WUXI BIO(02269) 393.5K shares at $109.9, $43.246M turnover http://www.aastocks.com/en/stocks/news/aamm-content/aat21052086/block-traded

u.a. WuXi Bio: Investitionen in Gesundheitsunternehmen aus Schwellenländern liegen im Trend. Welche Geschäftsmodelle besonders im Fokus stehen, erklärt Andreas Scharf, Analyst bei Apo Asset Management. https://www.dasinvestment.com/diese-gesundheitsunternehmen-stechen-hervor/

WuXi finanziert mit: https://www.prnewswire.com/news-releases/duality-biologics-completed-90-million-series-b-financing-301294736.html (Duality Biologics Completed $90 Million Series B Financing)

Feiertag heute in HK

WuXi Biologics and WuXi STA Jointly Established WuXi XDC to Provide Fully Integrated Bioconjugate CDMO Services https://www.prnewswire.com/news-releases/wuxi-biologics-and-wuxi-sta-jointly-established-wuxi-xdc-to-provide-fully-integrated-bioconjugate-cdmo-services-301291101.html

https://pub.webull.com/us/news-html/2ed113b12bcb49b085ae65c65dce183b.html?theme=2&_v=1&color=1&hl=en&sp=1&_v=1&theme=2&color=1&hl=en BRIEF-Shanghai Hile Bio-Tech, WuXi Biologics To Subscribe to Private Share Placement Of WuXi Vaccines

Summer.76 👍🏼

WuXi Biologics Completed Three Acquisitions to Enhance its Global Network https://finance.yahoo.com/news/wuxi-biologics-completed-three-acquisitions-003000120.html

Thursday picks: WuXi Biologics (02269) target price 130 yuan stop loss price 94 yuan http://www.aimpact.com/article/zho/%E5%91%A8%E5%9B%9B%E7%B2%BE%E9%81%B8-%E8%97%A5%E6%98%8E%E7%94%9F%E7%89%A9-02269-%E7%9B%AE%E6%A8%99%E5%83%B9130%E5%85%83-%E6%AD%A2%E8%9D%95%E5%83%B994%E5%85%83-3175307363

Bin bei beiden am Start und daher wahrscheinlich falsche Ansprechpartnerin bzgl der 'Entscheidung' 🙃. Wenn du dich informieren magst, schaue gerne die links durch, auch bei der AppTec. Die sind gerade hier doch ziemlich aktuell, bei der WuXi AppTec bin ich da nicht ganz so hinterher.

Hallo zusammen, bin gerade dran mich in das Unternehmen ein zu lesen. WuXi ein zu arbeiten. Was doch sehr komplex ist. Deshalb mal eine Frage zum vereinfachen. Wieso habt ihr euch für die Biologics Aktie entschieden und nicht für das Gesamtpaket WuXiApptec? Danke für eure Antworten.